| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |